BIO earnings · rev $651.0M
BIO (BIO) common stock.
This BIO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
When the next BIO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 9.9% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full BIO research stays on the stock page; the tape stays on the quote page.
Not investment advice.